Thumbnail
Access Restriction
Open

Author Donnelley, Martin ♦ Farrow, Nigel ♦ Parsons, David ♦ Morgan, Kaye ♦ Siu, Karen
Source United States Department of Energy Office of Scientific and Technical Information
Content type Text
Language English
Subject Keyword INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND TECHNOLOGY ♦ CLASSICAL AND QUANTUM MECHANICS, GENERAL PHYSICS ♦ COMPUTER CODES ♦ FIBROSIS ♦ GENES ♦ GLASS ♦ HYDRATION ♦ IMAGES ♦ LUNGS ♦ MICE ♦ MICROSCOPY ♦ NOSE ♦ PARTICLE TRACKS ♦ PARTICLES ♦ PATHOGENS ♦ REFRACTIVE INDEX ♦ SENSITIVITY ♦ SPRING-8 STORAGE RING ♦ SYNCHROTRONS ♦ THERAPY ♦ X RADIATION
Abstract Cystic fibrosis (CF) is caused by a gene defect that compromises the ability of the mucociliary transit (MCT) system to clear the airways of debris and pathogens. To directly characterise airway health and the effects of treatments we have developed a synchrotron X-ray microscopy method that non-invasively measures the local rate and patterns of MCT behaviour. Although the nasal airways of CF mice exhibit the CF pathophysiology, there is evidence that nasal MCT is not altered in CF mice1. The aim of this experiment was to determine if our non-invasive local airway health assessment method could identify differences in nasal MCT rate between normal and CF mice, information that is potentially lost in bulk MCT measurements. Experiments were performed on the BL20XU beamline at the SPring-8 Synchrotron in Japan. Mice were anaesthetized, a small quantity of micron-sized marker particles were delivered to the nose, and images of the nasal airways were acquired for 15 minutes. The nasal airways were treated with hypertonic saline or mannitol to increase surface hydration and MCT. Custom software was used to locate and track particles and calculate individual and bulk MCT rates. No statistically significant differences in MCT rate were found between normal and CF mouse nasal airways or between treatments. However, we hope that the improved sensitivity provided by this technique will accelerate the ability to identify useful CF lung disease-modifying interventions in small animal models, and enhance the development and efficacy of proposed new therapies.
ISSN 0094243X
Educational Use Research
Learning Resource Type Article
Publisher Date 2016-01-28
Publisher Place United States
Volume Number 1696
Issue Number 1


Open content in new tab

   Open content in new tab